RxNorm Names
SUNMARK HYDROCORTISONE
(hydrocortisone)
ointment
[McKesson]
Permanent Link:
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=210079e9-3d2f-4489-b468-b96b145034ed| Category | DEA Schedule | Marketing Status |
|---|---|---|
| HUMAN OTC DRUG LABEL | OTC monograph not final |
NOTE:MOST OTC DRUGS ARE NOT REVIEWED AND APPROVED BY FDA, HOWEVER THEY MAY BE MARKETED IF THEY COMPLY WITH APPLICABLE REGULATIONS AND POLICIES. FDA HAS NOT EVALUATED WHETHER THIS PRODUCT COMPLIES.
Uses
for the temporary relief of itching associated with minor skin irritations, inflammation and rashes due to:
- eczema
- seborrheic dermatitis
- psoriasis
- insect bites
- poison ivy, oak, sumac
- soaps
- detergents
- cosmetics
- jewelry
- external genital and anal itching
other uses of this product should be only under the advice and supervision of a doctor.
Warnings
- for external use only
- avoid contact with the eyes
- do not put this product into the rectum by using fingers or any mechanical device or applicator
Stop using this product and ask a doctor
- in case of bleeding
- if condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days
- before you begin using any other hydrocortisone product
Do not use this product and ask a doctor
- if you have a vaginal discharge
- before treating diaper rash
- before using on children under 2 years of age
Directions
- when practical, cleanse the affected area with mild soap and warm water and rinse thoroughly
- gently dry by patting or blotting with toilet tissue or a soft cloth before application of this product
- adults and children 12 years of age and older: apply to the affected area not more than 3 to 4 times daily
- children under 12 years of age: Do not use, consult a doctor
| SUNMARK
HYDROCORTISONE
hydrocortisone ointment |
|||||||||||||
|
|||||||||||||
|
|||||||||||||
|
|||||||||||||
|
|||||||||||||
|
|||||||||||||
| Labeler - McKesson (177667227) |
| Registrant - Taro Pharmaceuticals U.S.A., Inc. (145186370) |
| Establishment | |||
| Name | Address | ID/FEI | Business Operations |
| Taro Pharmaceuticals Inc. | 206263295 | MANUFACTURE(49348-522) | |
Revised: 02/2013
Document Id: 7f8d90f1-5da5-4307-bce4-487cc80fe71d
Set id: 210079e9-3d2f-4489-b468-b96b145034ed
Version: 1
Effective Time: 20130207
McKesson
Review RxNorm Normal Forms